BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8891923)

  • 1. High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection.
    Marfil F; Pineau V; Sioufi A; Godbillon SJ
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):251-8. PubMed ID: 8891923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, application and comparison of an enzyme immunoassay and a high-performance liquid chromatography method for the determination of the aromatase inhibitor CGS 20,267 in biological fluids.
    Pfister CU; Duval M; Godbillon J; Gosset G; Gygax D; Marfil F; Sioufi A; Winkler B
    J Pharm Sci; 1994 Apr; 83(4):520-4. PubMed ID: 8046607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated analysis of a novel anti-epileptic compound, CGP 33,101, and its metabolite, CGP 47,292, in body fluids by high-performance liquid chromatography and liquid-solid extraction.
    Rouan MC; Souppart C; Alif L; Moes D; Lecaillon JB; Godbillon J
    J Chromatogr B Biomed Appl; 1995 May; 667(2):307-13. PubMed ID: 7663704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole.
    Dange Y; Bhinge S; Salunkhe V
    Toxicol Mech Methods; 2018 Mar; 28(3):187-194. PubMed ID: 28980851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid determination of letrozole, citalopram and their metabolites by high performance liquid chromatography-fluorescence detection in urine: Method validation and application to real samples.
    Rodríguez J; Castañeda G; Muñoz L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jan; 913-914():12-8. PubMed ID: 23262245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of RP-HPLC method to determine letrozole in different pharmaceutical formulations and its application to studies of drug release from nanoparticles.
    Mondal N; Pal TK; Ghosal SK
    Acta Pol Pharm; 2009; 66(1):11-7. PubMed ID: 19226963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated quantitative determination of the new renin inhibitor CGP 60536 by high-performance liquid chromatography.
    Lefèvre G; Gauron S
    J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):129-36. PubMed ID: 10778934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the aromatase inhibitor letrozole and its carbinol metabolite in mouse plasma by UHPLC-MS/MS.
    Taheri H; Jin Y; Ahmed E; Hu P; Li Y; Sparreboom A; Hu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 May; 1238():124106. PubMed ID: 38636136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated and sensitive method for the determination of formoterol in human plasma by high-performance liquid chromatography and electrochemical detection.
    Campestrini J; Lecaillon JB; Godbillon J
    J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):221-9. PubMed ID: 9518154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective determination of unchanged and glucuroconjugated eliprodil, a new anti-ischaemic drug, in human plasma and urine by precolumn derivatization and column-switching high-performance liquid chromatography with fluorescence detection.
    Malavasi B; Ripamonti M; Rouchouse A; Ascalone V
    J Chromatogr A; 1996 Apr; 729(1-2):323-33. PubMed ID: 9004957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of two new forced degradation products of letrozole and development of a stability-indicating RP-LC method for its determination.
    Elkady EF; Fouad MA
    Pak J Pharm Sci; 2015 Nov; 28(6):2041-51. PubMed ID: 26639498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of CGP 61755, a protease inhibitor, in plasma and urine by high-performance liquid chromatography and fluorescence detection.
    Flesch G; Mann C; Degen PH
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):123-30. PubMed ID: 9300916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absolute bioavailability of letrozole in healthy postmenopausal women.
    Sioufi A; Gauducheau N; Pineau V; Marfil F; Jaouen A; Cardot JM; Godbillon J; Czendlik C; Howald H; Pfister C; Vreeland F
    Biopharm Drug Dispos; 1997 Dec; 18(9):779-89. PubMed ID: 9429742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of letrozole.
    Haynes BP; Dowsett M; Miller WR; Dixon JM; Bhatnagar AS
    J Steroid Biochem Mol Biol; 2003 Oct; 87(1):35-45. PubMed ID: 14630089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of carvedilol in human plasma by liquid chromatography using fluorescence detection: application in pharmacokinetic studies.
    Zarghi A; Foroutan SM; Shafaati A; Khoddam A
    J Pharm Biomed Anal; 2007 May; 44(1):250-3. PubMed ID: 17391893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput, semi-automated determination of a cyclooxygenase II inhibitor in human plasma and urine using solid-phase extraction in the 96-well format and high-performance liquid chromatography with post-column photochemical derivatization-fluorescence detection.
    Matthews CZ; Woolf EJ; Lin L; Fang W; Hsieh J; Ha S; Simpson R; Matuszewski BK
    J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(2):237-46. PubMed ID: 11236079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the aromatase inhibitor letrozole in urine by gas chromatography/mass spectrometry.
    Mareck U; Sigmund G; Opfermann G; Geyer H; Thevis M; Schänzer W
    Rapid Commun Mass Spectrom; 2005; 19(24):3689-93. PubMed ID: 16299697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid quantitative analysis of letrozole, fluoxetine and their metabolites in biological and environmental samples by MEKC.
    Rodríguez-Flores J; Contento Salcedo AM; Muñoz Fernández L
    Electrophoresis; 2009 Feb; 30(4):624-32. PubMed ID: 19180543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anastrozole quantification in human plasma by high-performance liquid chromatography coupled to photospray tandem mass spectrometry applied to pharmacokinetic studies.
    Mendes GD; Hamamoto D; Ilha J; Pereira Ados S; De Nucci G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):553-9. PubMed ID: 17240203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.
    Reddy YR; Nandan SR; Bharathi DV; Nagaraju B; Reddy SS; Ravindranath LK; Rao VS
    J Pharm Biomed Anal; 2009 Oct; 50(3):397-404. PubMed ID: 19541446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.